TDOC — Teladoc Health, Inc.
NYSE
Q1 2026 Earnings Call Summary
April 30, 2026
Summary of Teladoc Health Q1 2026 Earnings Call
1. Key Financial Results and Metrics
- Consolidated Revenue: $614 million, exceeding guidance midpoint.
- Adjusted EBITDA: $58 million, representing a 9.5% margin.
- Net Loss per Share: $0.36, impacted by amortization, stock-based compensation, and restructuring costs.
- Free Cash Flow: Net outflow of $26 million, ending with $751 million in cash and cash equivalents.
- Integrated Care Revenue: $395 million, a 1.5% year-over-year increase.
- BetterHelp Revenue: $218 million, down 9% year-over-year.
- Chronic Care Enrollment: 1.2 million, up 1% sequentially and 4% year-over-year.
2. Strategic Updates and Business Highlights
- Market Position: Teladoc has established a leading position in Integrated Care, focusing on comprehensive care solutions for chronic conditions and mental health.
- Service Enhancements: Improved 24/7 care offering and integration of AI to enhance patient engagement and operational efficiency.
- BetterHelp Expansion: Successful rollout of insurance offerings, now live in 30 states, with over 6,000 credentialed providers and 150 million insurance contracted lives.
- Mental Health Services: Nearly $140 million in revenue from mental health services in 2025, with growth continuing into Q1 2026.
- Operational Efficiency: Focus on cost structure improvements and AI-driven efficiencies, particularly in BetterHelp.
3. Forward Guidance and Outlook
- 2026 Revenue Guidance: Expected between $2.48 billion and $2.58 billion.
- Adjusted EBITDA Guidance: Projected between $267 million and $306 million.
- Free Cash Flow Guidance: Anticipated between $130 million and $170 million.
- BetterHelp Revenue Guidance: Expected to decline between 6.5% and 1.0% versus 2025, with insurance revenue projected at $90 million to $105 million.
- Integrated Care Revenue Growth: Expected to grow 0.8% to 3.5% for the full year.
4. Bad News, Challenges, or Points of Concern
- BetterHelp Performance: Continued pressure on the direct-to-consumer cash pay business, with a 9% decline in average paying users.
- Membership Trends: Potential moderation in Integrated Care membership due to ACA subsidy-related disenrollment and changes in health plan enrollments.
- Margin Pressure: Lower margins expected in the insurance segment compared to direct-to-consumer due to higher administrative costs.
- Implementation Delays: Some contract implementations pushed to the second half of 2026, affecting near-term revenue visibility.
5. Notable Q&A Insights
- Integrated Care Growth: Management expressed confidence in returning to growth, driven by the shift from subscription to visit-based revenue models.
- BetterHelp Insurance Rollout: Positive early results from insurance offerings, with higher session engagement among insured users, though some cannibalization from cash pay expected.
- Chronic Care Market: Encouraging signs in the selling season, with a focus on bundled products and comprehensive solutions to meet client needs.
- CFO Search: Ongoing search for a new CFO, with emphasis on finding a candidate that fits well with the management team and organizational needs.
Overall, Teladoc Health reported solid financial results for Q1 2026, with strategic initiatives aimed at enhancing service offerings and expanding insurance coverage. However, challenges remain in the form of declining metrics in the BetterHelp segment and potential headwinds from market dynamics and implementation delays.
